Therapeutic Germ Line Alteration: Has CRISPR/Cas9 Technology Forced the Question?
Incoming Editor-in-Chief.
Terence R
TR
Flotte
D064113:CRISPR-Cas Systems; D015316:Genetic Therapy / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods; D005854:Germ Cells / Q000378:metabolism*; D006801:Humans